Wanbury Ltd, one of the fastest growing pharma companies in the domestic market, has launched its New Drug Delivery System (NDDS) product Nitrofur SR (Nitrofurantoin-100mg, sustained release) targeted at Urinary Tract Infections (UTI), for the first time in India. Wanbury is the third company in India to have entered the unexplored market of Nitrofurantoin.
The details can be read here.
No comments:
Post a Comment